600513 联环药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.5686.12110.30311.66110.660
总资产报酬率 ROA (%)-0.9842.8654.8475.5775.397
投入资产回报率 ROIC (%)-1.2983.6966.4167.4617.323

边际利润分析
销售毛利率 (%)34.49049.37448.13753.34854.631
营业利润率 (%)2.8556.0648.0399.5679.493
息税前利润/营业总收入 (%)1.1057.1239.22310.71810.800
净利润/营业总收入 (%)-1.3314.9266.9618.5138.500

收益指标分析
经营活动净收益/利润总额(%)-3,607.62984.49690.236100.86797.452
价值变动净收益/利润总额(%)198.884-8.117-0.241-1.514-0.941
营业外收支净额/利润总额(%)4,071.257-0.4530.1491.0612.087

偿债能力分析
流动比率 (X)1.1391.1031.0861.1001.182
速动比率 (X)0.7910.7750.8330.8760.983
资产负债率 (%)57.72347.76546.86747.92845.604
带息债务/全部投入资本 (%)54.34740.40737.12337.35133.651
股东权益/带息债务 (%)81.230145.145167.777166.714196.041
股东权益/负债合计 (%)56.28496.766101.18097.342107.845
利息保障倍数 (X)0.9396.5607.87110.2249.772

营运能力分析
应收账款周转天数 (天)83.32785.52180.90880.47783.813
存货周转天数 (天)106.150124.21394.95995.11695.837